Liposomal Lactoferrin and Liposomal Lactoferrin plus Zinc Induces Antiinflammatory and Immunomodulatory Effects by Activation of IFNγ

In both developing and developed nations, pulmonary diseases are the major cause of mortality and disability. There has been a worldwide increase in the incidence of both acute and chronic respiratory illnesses, which poses a serious problem for the healthcare system. Lung cancer seems to be just one form of a parenchymal lung disorder, but there are many others, including chronic obstructive pulmonary disease (COPD), asthma, occupational lung diseases (asbestosis, pneumoconiosis), etc. Notably, chronic respiratory disorders cannot be cured, and acute abnormalities are notoriously difficult to treat. As a result, it is possible that therapeutic objectives could be achieved using nanotechnology in the form of either improved pharmacological efficacy or reduced toxicity. In addition, the incorporation of various nanostructures permits the enhancement of medication bioavailability, transport, and administration. Medicines and diagnostics based on nanotechnology have progressed significantly toward clinical application for the treatment of lung cancers. In recent years, scientists have shifted their focus towards exploring the potential of nanostructures in the treatment of other relevant respiratory illnesses. Micelles and polymeric nanoparticles are the two most studied nanostructures in a wide range of diseases. This study concludes with a summary of recent and pertinent research in drug delivery systems for the treatment of various pulmonary disorders, as well as trends, limitations, significance, and treatment and diagnostics employing nanotechnology, as well as future studies in this domain.

show abstract

Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases

Dhoundiyal

Alam

Kaur

et al. 2024

PNT

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Liposomal Lactoferrin and Liposomal Lactoferrin plus Zinc Induces Antiinflammatory and Immunomodulatory Effects by Activation of IFNγ

Cited by 1 publication

References 0 publications

Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases

Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases

Contact Info

Product

Resources

About